Techpool Bio-Pharma

CompanyChina

ROR

Techpool Bio-Pharma develops one asset, in phase 1 (ulinastatin in ulinastatin). Mostly protein or enzyme; based in China.

1
Asset
Furthest stage
Phase 1
1
Trial
2
Signals

Pipeline

1
  • ulinastatin

    Inhibits serine proteases, including trypsin and neutrophil elastase, limiting inflammation and tissue injury.

    Phase 1, Protein or enzyme, ulinastatin

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials1
  • Signals4

Intelligence